Cargando…

Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran

OBJECTIVE(S): Resistance to carbapenems as the last line for controlling resistant bacteria is increasing due to production of carbapenemase. The aim of this study was to detect the plasmid-encoded carbapenemases using phenotypic methods and multiplex PCR among the multi-drug resistant (MDR) isolate...

Descripción completa

Detalles Bibliográficos
Autores principales: Deldar Abad Paskeh, Mahshid, Mehdipour Moghaddam, Mohammad Javad, Salehi, Zivar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374986/
https://www.ncbi.nlm.nih.gov/pubmed/32742595
http://dx.doi.org/10.22038/ijbms.2020.34563.8199
_version_ 1783561796190208000
author Deldar Abad Paskeh, Mahshid
Mehdipour Moghaddam, Mohammad Javad
Salehi, Zivar
author_facet Deldar Abad Paskeh, Mahshid
Mehdipour Moghaddam, Mohammad Javad
Salehi, Zivar
author_sort Deldar Abad Paskeh, Mahshid
collection PubMed
description OBJECTIVE(S): Resistance to carbapenems as the last line for controlling resistant bacteria is increasing due to production of carbapenemase. The aim of this study was to detect the plasmid-encoded carbapenemases using phenotypic methods and multiplex PCR among the multi-drug resistant (MDR) isolates from patients with urinary tract infection (UTI) in northern Iran. MATERIALS AND METHODS: Antimicrobial susceptibility testing and extended spectrum β-lactamase (ESBL) production test were performed for 91 MDR Escherichia coli strains by disc diffusion and double disk synergy tests (DDST), respectively. Carbapenemases production was confirmed using Hodge test, EDTA double disk synergy test (EDST) and combined disk test (CDT). The isolates were subjected to PCR targeting bla(IMP), bla(VIM), bla(KPC) and bla(OXA-48) β-Lactamase genes. RESULTS: Resistance of isolates to 1(st), 2(nd), 3(rd), and 4(th) generations of cephalosporins, carbapenems, and penicillins were 73%, 84.5%, 62%, 37.5%, 17.5%, and 76%, respectively. Based on CDT and Hodge test, 1 (3%) and based on EDST, 2 (6%) of 33 ESBL producers synthesize a type of carbapenemase. The frequency of bla(IMP), bla(VIM), bla(KPC), and bla(OXA-48) genes was 8.7%, 9.8%, 2.1%, and 15.3%, respectively. Existence of bla(IMP) conferred more resistance to cephalotin, fosfomycin, and piperacillin (P≤0.01) and carrying bla(VIM) caused more resistance to cephalotin, cefepime, and ceftazidime (P≤0.01). The presence of bla(KPC) conferred more resistance to cephalotin and presence of bla(OXA-48) caused more resistance to chloramphenicol and piperacillin (P≤0.05). CONCLUSION: Identification and controlling of this nearly low frequent ESBL and carbapenemase producing strains are important due to the presence of plasmid genes encoding carbapenemase.
format Online
Article
Text
id pubmed-7374986
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-73749862020-07-31 Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran Deldar Abad Paskeh, Mahshid Mehdipour Moghaddam, Mohammad Javad Salehi, Zivar Iran J Basic Med Sci Original Article OBJECTIVE(S): Resistance to carbapenems as the last line for controlling resistant bacteria is increasing due to production of carbapenemase. The aim of this study was to detect the plasmid-encoded carbapenemases using phenotypic methods and multiplex PCR among the multi-drug resistant (MDR) isolates from patients with urinary tract infection (UTI) in northern Iran. MATERIALS AND METHODS: Antimicrobial susceptibility testing and extended spectrum β-lactamase (ESBL) production test were performed for 91 MDR Escherichia coli strains by disc diffusion and double disk synergy tests (DDST), respectively. Carbapenemases production was confirmed using Hodge test, EDTA double disk synergy test (EDST) and combined disk test (CDT). The isolates were subjected to PCR targeting bla(IMP), bla(VIM), bla(KPC) and bla(OXA-48) β-Lactamase genes. RESULTS: Resistance of isolates to 1(st), 2(nd), 3(rd), and 4(th) generations of cephalosporins, carbapenems, and penicillins were 73%, 84.5%, 62%, 37.5%, 17.5%, and 76%, respectively. Based on CDT and Hodge test, 1 (3%) and based on EDST, 2 (6%) of 33 ESBL producers synthesize a type of carbapenemase. The frequency of bla(IMP), bla(VIM), bla(KPC), and bla(OXA-48) genes was 8.7%, 9.8%, 2.1%, and 15.3%, respectively. Existence of bla(IMP) conferred more resistance to cephalotin, fosfomycin, and piperacillin (P≤0.01) and carrying bla(VIM) caused more resistance to cephalotin, cefepime, and ceftazidime (P≤0.01). The presence of bla(KPC) conferred more resistance to cephalotin and presence of bla(OXA-48) caused more resistance to chloramphenicol and piperacillin (P≤0.05). CONCLUSION: Identification and controlling of this nearly low frequent ESBL and carbapenemase producing strains are important due to the presence of plasmid genes encoding carbapenemase. Mashhad University of Medical Sciences 2020-05 /pmc/articles/PMC7374986/ /pubmed/32742595 http://dx.doi.org/10.22038/ijbms.2020.34563.8199 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Deldar Abad Paskeh, Mahshid
Mehdipour Moghaddam, Mohammad Javad
Salehi, Zivar
Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
title Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
title_full Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
title_fullStr Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
title_full_unstemmed Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
title_short Prevalence of plasmid-encoded carbapenemases in multi-drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
title_sort prevalence of plasmid-encoded carbapenemases in multi-drug resistant escherichia coli from patients with urinary tract infection in northern iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374986/
https://www.ncbi.nlm.nih.gov/pubmed/32742595
http://dx.doi.org/10.22038/ijbms.2020.34563.8199
work_keys_str_mv AT deldarabadpaskehmahshid prevalenceofplasmidencodedcarbapenemasesinmultidrugresistantescherichiacolifrompatientswithurinarytractinfectioninnortherniran
AT mehdipourmoghaddammohammadjavad prevalenceofplasmidencodedcarbapenemasesinmultidrugresistantescherichiacolifrompatientswithurinarytractinfectioninnortherniran
AT salehizivar prevalenceofplasmidencodedcarbapenemasesinmultidrugresistantescherichiacolifrompatientswithurinarytractinfectioninnortherniran